Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
275 hedge funds and large institutions have $3.91B invested in Immunogen Inc in 2023 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 118 increasing their positions, 72 reducing their positions, and 35 closing their positions.
66% more call options, than puts
Call options by funds: $55.1M | Put options by funds: $33.2M
64% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 72
31% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 35
3% more funds holding
Funds holding: 266 → 275 (+9)
8% less capital invested
Capital invested by funds: $4.24B → $3.91B (-$327M)
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$183M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$58.3M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$36.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$31.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$164M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$51.2M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$28.7M |
| 4 |
First Manhattan
New York
|
-$23.7M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$21.1M |
IMGN Hedge Fund Activity: Q3 2023 in Review
275 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2023, worth a combined $3.91B — down 7.7% from $4.24B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new IMGN positions and 35 closed out — a net gain of 11 holders — while 118 added to existing stakes and 72 trimmed.
The largest buyer was RA Capital Management, adding an estimated $183M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $164M sold.
- 275 institutional investors held Immunogen Inc (IMGN) as of Q3 2023, up from 266 in Q2 2023.
- Funds reported $3.91B of Immunogen Inc stock for Q3 2023, down 7.7% quarter-over-quarter.
- 46 funds opened new Immunogen Inc positions in Q3 2023 and 35 closed out, a net change of +11 holders.
- The largest Immunogen Inc buyer in Q3 2023 was RA Capital Management, an estimated $183M added.
- The largest Immunogen Inc seller in Q3 2023 was Point72 Asset Management, an estimated $164M sold.
Based on aggregated 13F filings for Q3 2023.